• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

by Fred Pennic 08/23/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative

What You Should Know:

– Optellum, a lung-health medtech startup that is pioneering the use of AI to improve diagnostic accuracy and clinical decision-making announce a strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative. This announcement accelerates Optellum’s market entry, building on its FDA clearance earlier this year and deployments underway at hospitals in the USA and ongoing clinical trials in the United Kingdom.

– As part of the collaboration, Optellum will provide its AI-powered clinical decision support platform with the goal of increasing lung cancer survival rates through early intervention and prevention.

– At the core of the collaboration is Optellum’s commercial software, Virtual Nodule Clinic, including an AI-powered digital biomarker based on neural networks and imaging analytics. It identifies and tracks at-risk patients and assigns a Lung Cancer Prediction score to lung nodules: small lesions, frequently detected in chest Computed Tomography (CT) scans that may or may not be cancerous. The Optellum AI will be used to drive accurate early diagnosis and optimal treatment decisions with the aim of treating patients earlier, potentially at a pre-cancerous stage, increasing survival rates.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Artificial Intelligence, lung

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Rethinking Big Data in 2024: How Healthcare Can Leverage Workforce Intelligence to Improve Care

Rethinking Big Data in 2024: How Healthcare Can Leverage Workforce Intelligence to Improve Care

Qualtrics and Epic Partner for Integrated Data-Driven Experience

Qualtrics and Epic Partner for Integrated Data-Driven Experience

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

Clover Health Exits CMS ACO REACH Program to Focus on Medicare Advantage

Clover Health Exits CMS ACO REACH Program to Focus on Medicare Advantage

Cigna to Acquire Express Scripts for $67B: 5 Things to Know

Cigna and Humana Merger Talks Could Face Antitrust Scrutiny

RNSA23: Cleveland Clinic and Canon Partner to Pioneer Next-Gen Imaging Technologies

RSNA23: Cleveland Clinic and Canon to Establish Comprehensive Imaging Research Center

Automating Implant Orders: A Turning Point in Healthcare’s Digital Transformation

Automating Implant Orders: A Turning Point in Healthcare’s Digital Transformation

Consumers Believe Generative AI Can Revolutionize Healthcare

71% of Consumers Believe Generative AI Can Revolutionize Healthcare

NCQA Launches Virtual Care Accreditation Pilot

NCQA Launches Virtual Care Accreditation Pilot

Novant Health Acquires Three Tenet Hospitals in South Carolina for $2.4 Billion

M&A: Novant Health Acquires 3 Tenet Hospitals in South Carolina for $2.4B

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |